L-Lysine
L-Lysine is an essential amino acid taken mainly for herpes cold-sore prevention and as a building block for collagen and protein.
L-Lysine at a Glance
L-Lysine is an essential amino acid — one the body cannot synthesise — and an obligatory substrate for protein synthesis, collagen crosslinking via hydroxylysine, and carnitine biosynthesis.
The decision-relevant question is almost never does the body need lysine (it clearly does), but does extra lysine, on top of an adequate diet, do anything. For the flagship claim — preventing herpes cold sores — the human trials are genuinely split, and the highest-tier review found no convincing effect. Several of the other positive signals, including the anxiety work, are strongest in people who were short on lysine to begin with.
That deficiency angle is not hypothetical. Lysine is the limiting amino acid in cereal grains, so populations relying on wheat, rice or maize as a staple genuinely can fall short — which is why lysine is the classic target for grain fortification, and why the clearest anxiety result came from a fortification trial in Syria rather than from a supplement study.
Lysine is sold almost entirely as the hydrochloride salt (about 80% lysine by weight), which is well absorbed. Form is rarely the limiting factor here — dose and baseline dietary adequacy are.
What It’s Used For
- Herpes cold-sore prophylaxis — the flagship use, and genuinely contested.
- Anxiety & stress — modest, mostly in low-lysine or high-anxiety subgroups, and industry-sponsored.
- Calcium absorption — one small study, surrogate endpoint only.
Two things worth separating. For active cold-sore lesions — treatment rather than prevention — trials have generally shown no benefit. And “collagen support” for skin and connective tissue is biochemically true but clinically unevidenced: lysine is a genuine collagen substrate, and no trial shows supplemental lysine improves those outcomes when the diet is already adequate.
How It Works
The herpes rationale is a competition. In cell culture, a high lysine-to-arginine ratio suppresses herpes simplex replication, because HSV replication favours arginine. Lysine and arginine share the same cationic amino-acid transporters — in the gut and in renal reabsorption — so loading one displaces the other. That is also why lysine is usually taken between meals: to avoid competing with dietary amino acids for the same route.
Note that this cuts both ways with the anxiety evidence, where lysine and arginine were given together rather than in opposition.
Beyond that, lysine is the substrate for lysyl hydroxylase, producing the hydroxylysine that forms mature collagen crosslinks, and it is the precursor from which carnitine is built. Its stress effects appear to run through the HPA axis — lower basal cortisol and a blunted sympatho-adrenal response — with some animal evidence pointing at serotonergic (5-HT₄) signalling in the gut.
The full trial record is in Pharmacology & Research below.
Pharmacology & Research
L-Lysine is an essential (indispensable) amino acid — one the body cannot synthesise and must obtain from diet — and an obligatory substrate for protein synthesis, collagen crosslinking (via hydroxylysine), and carnitine biosynthesis. As a supplement its evidence posture is modest and use-specific: the decision-relevant question is almost never “does the body need lysine” (it clearly does) but “does extra lysine, on top of an adequate diet, do anything.” For the flagship claim — preventing herpes cold sores — the human trials are genuinely split and the highest-tier review (Cochrane) found no convincing effect, while several of the positive signals (anxiety, deficiency correction) are strongest in people who were short on lysine to begin with. Lysine is sold almost entirely as the hydrochloride salt (L-lysine HCl, ~80% lysine by weight), which is well absorbed; form is rarely the limiting factor here — dose and baseline dietary adequacy are.
Support is an experimental score I’m building — a composite weighted by study type (human > animal > in vitro > review) and study volume. It’s a beta: a fast way to rank strength of evidence at a glance, not a validated metric. Each application links down to its write-up.
The rationale is biochemical: in cell culture, a high lysine-to-arginine ratio suppresses herpes simplex virus (HSV) replication, because HSV replication favours arginine 1Reference 1Clinical trialA multicentered study of lysine therapy in herpes simplex infection — clinical trialView study →.
In humans the picture is inconsistent. Early open and controlled work reported fewer, milder recurrences. A 1978 multicentre study of 45 patients on 312–1,200 mg/day reported accelerated recovery and suppressed recurrence 1Reference 1Clinical trialA multicentered study of lysine therapy in herpes simplex infection — clinical trialView study →.
A 12-month double-blind crossover in 26 people found significantly fewer lesions on 1,000 mg/day, with recurrence rising when lysine was stopped and a serum-lysine threshold (~165 nmol/mL) tracking benefit 2Reference 2Clinical trialLysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis — crossover clinical trialView study →.
A 6-month double-blind RCT (n=52) on 3 × 1,000 mg/day reported about 2.4 fewer infections plus reduced severity and healing time 3Reference 3RCTSuccess of L-lysine therapy in frequently recurrent herpes simplex infection — randomised controlled trialView study →.
Against these, a double-blind RCT on 1,200 mg/day (n=21) found no benefit for treatment or prevention 4Reference 4RCTFailure of lysine in frequently recurrent herpes simplex infection — randomised controlled trialView study →; a crossover trial (n=65) on 1,000 mg/day found no overall effect on recurrence, though more patients stayed recurrence-free on lysine (p=0.05) 5Reference 5RCTLysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study — randomised controlled trialView study →; and the 2015 Cochrane review of cold-sore prophylaxis concluded it failed to find any evidence of efficacy for lysine 6Reference 6Systematic reviewInterventions for prevention of herpes simplex labialis (cold sores on the lips) — systematic reviewView study →.
A 2017 narrative review reconciled this by dose: under 1 g/day without a low-arginine diet appears ineffective, while above 3 g/day appears to improve patients’ subjective experience 7Reference 7ReviewLysine for herpes simplex prophylaxis: a review of the evidence — reviewView study →.
Gap: the positive trials are older, small, and several are linked to the same investigators; the single highest-tier synthesis (Cochrane) is negative. Benefit, if real, likely requires ≥1 g/day — better ≥3 g/day — and may only appear in a subset of frequent recurrers.
Lysine is the limiting amino acid in cereal-based diets, and inadequacy raises stress-induced anxiety in animals. Three small human RCTs — all associated with the same manufacturer’s research institute — support a modest anxiolytic effect. A 3-month double-blind trial fortifying wheat with lysine in poor Syrian communities reduced trait anxiety in males and blunted the cortisol and sympathetic stress response 8Reference 8RCTLysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria — randomised controlled trialView study →.
A 1-week RCT in 108 healthy Japanese adults giving L-lysine 2.64 g/day plus L-arginine 2.64 g/day reduced trait and state anxiety and lowered basal salivary cortisol in men 9Reference 9RCTOral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans — randomised controlled trialView study →.
A 10-day RCT (n=29) in high-trait-anxiety subjects found the lysine + arginine mixture normalised the neuroendocrine response to a public-speaking stressor 10Reference 10RCTSubchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety — randomised controlled trialView study →.
Gap: all three key trials share sponsorship from a lysine manufacturer, samples are small, and the clearest effects appear in people with low baseline lysine intake or high trait anxiety — partly deficiency- and subgroup-dependent, and often paired with arginine rather than lysine alone.
A single human study tested whether lysine aids calcium handling. Co-administering 400 mg L-lysine with an oral calcium load blunted urinary calcium loss in healthy women, and 800 mg/day L-lysine — but not valine or tryptophan — significantly increased intestinal ⁴⁷Ca fractional absorption in 45 osteoporotic patients 11Reference 11Clinical trialDietary L-lysine and calcium metabolism in humans — clinical studyView study →.
Gap: one small study of a surrogate endpoint (fractional absorption), with no clinical bone-density or fracture outcomes and no replication; not a basis for taking lysine for bone health.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| HSV replication (arginine-dependent) | ↓ when the lysine:arginine ratio is high (in vitro) | Cold-sore prophylaxis |
| HPA axis / cortisol & sympatho-adrenal tone | ↓ basal cortisol, blunted stress response | Anxiety & stress |
| Serotonergic (5-HT₄) signalling in the gut | Modulated (animal data) | Anxiety & stress |
| Intestinal calcium transport | ↑ fractional Ca absorption | Calcium absorption |
| Lysyl hydroxylase → hydroxylysine crosslinks | Substrate for collagen maturation | Collagen (biochemistrynot a proven supplement effect) |
| Lysine → carnitine biosynthesis | Precursor | Fatty-acid oxidation (basal metabolism) |
Pharmacokinetics
Supplemental lysine is sold as L-lysine monohydrochloride — about 80% lysine by weight, so a “1,000 mg lysine” dose is roughly 1,250 mg of the salt. Free-form lysine is absorbed in the small intestine via cationic amino-acid transporters, sharing that route with arginine and ornithine, which is the basis for lysine–arginine competition.
Absorption of free lysine is efficient at gram-level doses, and plasma lysine rises within about 1–2 hours. It is not appreciably stored: excess is catabolised via saccharopine to acetyl-CoA, or excreted renally. There is no meaningful “form” debate as there is for minerals — the HCl salt is the standard and is well absorbed 12Reference 12ReviewThe metabolic roles, pharmacology, and toxicology of lysine — reviewView study →. Taking lysine on an empty stomach avoids competition from other dietary amino acids for transport, which is the usual rationale for dosing it between meals for the herpes indication.
Clinical trials
Lysine is an off-patent commodity amino acid, so there is little industry incentive for large modern trials. Most human data are small studies from the 1980s (herpes) or manufacturer-sponsored trials from the 2000s (anxiety), with no recent large RCTs registered for either indication.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| ~10(small) | Few | 0known | Many(in vitro/animal) |
Last checked: August 2026.
Dietary Sources
Lysine is abundant in animal proteins and legumes but is the limiting amino acid in cereal grains — which is why populations relying on wheat, rice or maize as a staple can fall short, and why lysine is the classic target for grain fortification. Refining and milling grains lowers it further, and dry-heat cooking (the Maillard reaction) can bind lysine and reduce its bioavailability.
| Food (typical serving) | Approx. lysine |
|---|---|
| Beef / pork / poultry (100 g cooked) | ~2,000–3,000 mg |
| Fish (100 g) | ~1,800–2,500 mg |
| Lentils / beans (1 cup cooked) | ~1,000–1,600 mg |
| Eggs (2 large) | ~900 mg |
| Tofu / soy (100 g) | ~700–900 mg |
| Cheese, hard (30 g) | ~600–800 mg |
| Milk / yoghurt (1 cup) | ~600–800 mg |
| Wheat bread (2 slices) | ~150–250 mg (limiting) |
Anyone eating adequate animal protein, or a well-combined legume-inclusive diet, comfortably meets the requirement. Supplemental lysine targets a pharmacological dose — grams — rather than filling a dietary gap, except in genuinely cereal-dominant diets 13Reference 13Dietary lysine requirements of older adults stratified by age and sex — indicator amino acid oxidation studyView study →.
Intake & Dosage
These are doses studied in research, not a personal recommendation.
The estimated adult requirement is roughly 38 mg/kg/day — about 2.6 g/day for a 70 kg adult — nearly always met by a normal diet 13Reference 13Dietary lysine requirements of older adults stratified by age and sex — indicator amino acid oxidation studyView study →. Supplemental, pharmacological use is a different question:
- Cold-sore prophylaxis: ~1,000 mg/day in most positive trials. The 2017 review argues doses
below 1 g/day are ineffective, and that above 3 g/day is where subjective benefit appears
2,
7Reference 2Clinical trialLysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis — crossover clinical trialView study →Reference 7ReviewLysine for herpes simplex prophylaxis: a review of the evidence — reviewView study → . - Active lesions or higher-dose regimens: studied at roughly 1–3 g/day, sometimes split
3,
7Reference 3RCTSuccess of L-lysine therapy in frequently recurrent herpes simplex infection — randomised controlled trialView study →Reference 7ReviewLysine for herpes simplex prophylaxis: a review of the evidence — reviewView study → . - Anxiety trials: ~2.6 g/day lysine, usually paired with ~2.6 g/day arginine 9Reference 9RCTOral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans — randomised controlled trialView study →.
- Watch the salt weight. Supplements are L-lysine HCl (~80% lysine), so “1,000 mg lysine” is roughly 1,250 mg of salt — check whether a label states lysine or lysine HCl.
- Timing: lysine is often taken between meals or on an empty stomach so it does not compete with other dietary amino acids for absorption.
- No Upper Limit has been set, so avoid open-ended megadosing.
Safety
L-Lysine has a long record of safe use as a food and feed additive and is well tolerated at supplemental gram-level doses; its acute toxicity is low 12Reference 12ReviewThe metabolic roles, pharmacology, and toxicology of lysine — reviewView study →.
- Long record of safe use. Low acute toxicity as a food and feed additive, well tolerated at gram-level supplemental doses 12Reference 12ReviewThe metabolic roles, pharmacology, and toxicology of lysine — reviewView study →.
- GI upset is the dose-limiting effect. Abdominal cramps and diarrhoea with high chronic intake.
- Caution in renal impairment. Lysine is cleared renally, so high doses warrant care.
- Increases calcium absorption and retention 11Reference 11Clinical trialDietary L-lysine and calcium metabolism in humans — clinical studyView study → — worth knowing if pairing high-dose lysine with high-dose calcium.
- Competes with arginine for transport and renal reabsorption. Usually not clinically important — but it is the same mechanism the herpes use relies on.
- No upper limit is set. One review additionally flags theoretical caution in cardiovascular or gallbladder disease at high doses 7Reference 7ReviewLysine for herpes simplex prophylaxis: a review of the evidence — reviewView study →.
Full Safety & Interactions Detail
The dose-limiting adverse effect is gastrointestinal — abdominal cramps and diarrhoea with high chronic intake.
- Renal clearance: lysine is cleared renally, so people with renal impairment should be cautious with high doses.
- Arginine competition: lysine and arginine compete for the same transporter and for renal reabsorption, so very high lysine can lower arginine handling. This is usually not clinically important — but the mechanism is precisely what the herpes use depends on.
- Interactions: lysine can modestly increase calcium absorption and retention 11Reference 11Clinical trialDietary L-lysine and calcium metabolism in humans — clinical studyView study →, so pairing high-dose lysine with high-dose calcium supplements warrants awareness. No major, well-documented drug interactions are established, but formal interaction screening is limited. One review additionally flagged theoretical caution in cardiovascular or gallbladder disease at high doses 7Reference 7ReviewLysine for herpes simplex prophylaxis: a review of the evidence — reviewView study →.
Scope disclosure. Interactions were assessed partially — the calcium interaction and the arginine-transport competition were reviewed; formal drug-interaction screening is limited. Pregnancy and lactation were assessed: dietary lysine is essential and safe, but supplemental gram-level doses have not been adequately studied. No Upper Limit has been set, and absence of reports is not evidence of safety. Where something was not studied, it is marked “not assessed,” not “safe.”
Not established — use only dietary amounts unless a clinician advises otherwise. Dietary lysine is essential and safe in pregnancy, but supplemental gram-level doses have not been adequately studied for safety in pregnancy or lactation.
References
- Griffith RS, Norins AL, Kagan C (1978). A multicentered study of lysine therapy in herpes simplex infection — clinical trial. Dermatologica. https://pubmed.ncbi.nlm.nih.gov/640102/
- Thein DJ, Hurt WC (1984). Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis — crossover clinical trial. Oral Surgery, Oral Medicine, Oral Pathology. https://pubmed.ncbi.nlm.nih.gov/6438572/
- Griffith RS, Walsh DE, Myrmel KH, et al. (1987). Success of L-lysine therapy in frequently recurrent herpes simplex infection — randomised controlled trial. Dermatologica. https://pubmed.ncbi.nlm.nih.gov/3115841/
- DiGiovanna JJ, Blank H (1984). Failure of lysine in frequently recurrent herpes simplex infection — randomised controlled trial. Archives of Dermatology. https://pubmed.ncbi.nlm.nih.gov/6419679/
- Milman N, Scheibel J, Jessen O (1980). Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study — randomised controlled trial. Acta Dermato-Venereologica. https://pubmed.ncbi.nlm.nih.gov/6153847/
- Chi CC, Wang SH, Delamere FM, et al. (2015). Interventions for prevention of herpes simplex labialis (cold sores on the lips) — systematic review. Cochrane Database of Systematic Reviews. https://pubmed.ncbi.nlm.nih.gov/26252373/
- Mailoo VJ, Rampes S (2017). Lysine for herpes simplex prophylaxis: a review of the evidence — review. Integrative Medicine (Encinitas). https://pubmed.ncbi.nlm.nih.gov/30881246/
- Smriga M, Ghosh S, Mouneimne Y, et al. (2004). Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria — randomised controlled trial. Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/15159538/
- Smriga M, Ando T, Akutsu M, et al. (2007). Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans — randomised controlled trial. Biomedical Research. https://pubmed.ncbi.nlm.nih.gov/17510493/
- Jezova D, Makatsori A, Smriga M, et al. (2005). Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety — randomised controlled trial. Nutritional Neuroscience. https://pubmed.ncbi.nlm.nih.gov/16117182/
- Civitelli R, Villareal DT, Agnusdei D, et al. (1992). Dietary L-lysine and calcium metabolism in humans — clinical study. Nutrition. https://pubmed.ncbi.nlm.nih.gov/1486246/
- Flodin NW (1997). The metabolic roles, pharmacology, and toxicology of lysine — review. Journal of the American College of Nutrition. https://pubmed.ncbi.nlm.nih.gov/9013429/
- Rafii M, Paoletti A, He H, et al. (2024). Dietary lysine requirements of older adults stratified by age and sex — indicator amino acid oxidation study. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/38735574/
